Sara Badia
Universitari Germans Trias i Pujol, Spain
Title: Perceval S and coronary artery bypass grafting, contradiction or full harmony?
Biography
Biography: Sara Badia
Abstract
Background / Study Objective:Coronary artery disease is common in patients who undergo an aortic valve replacement.Concomitant coronary artery bypass grafting (CABG) procedure does not necessarily contradict with the use of last generation sutureless bioprosthesis, but, publications about this combined approach are very scarce.
The objective of this study is to describe the results of aortic valve replacement with Perceval S bioprosthesis with concomitant CABG in our Center.
Methods: From our database we retrospectively described the outcomes of 42 patients who underwent aortic valve replacement with a last generation sutureless bioprosthesis (Perceval S) with CABG at the same procedure.It was used as graft: left internal mammary artery (LIMA), right internal mammary artery (RIMA), radial artery and safena vein.
From 1 to 3 arteries were revascularized per patient.
Mean age: 78,19±5,1. They were mostly man (women 35,7%).
Cardiovascular risk factors: Hipertension 97,6%; Diabetes 38,1%, obstructive pulmonary disease 21,4% of the patients.
Mean Logistic EuroScore II 10,73%.
Results. Table 1: Surgical Outcomes
Results. Table 2: Complications
Conclusions: Excellent results were achieved in patients undergoing aortic valve replacement with Perceval S sutureless bioprosthesis and concomitant coronary artery bypass grafting. Although high aortotomy is needed for Perceval S implantation, is possible to perform CABG also with safena vein if necessary in a safely way.Perceval S is a feasible alternative for patients with aortic valve stenosis and coronary heart disease, shortening the crossclamp time, extracorporeal circulation time and comorbidities derived therefrom.
